Teva Pharmaceuticals
TEVA
TEVA
835 hedge funds and large institutions have $32.1B invested in Teva Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 305 increasing their positions, 316 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $40B → $32.1B (-$7.95B)
32% less first-time investments, than exits
New positions opened: 69 | Existing positions closed: 101
39% less funds holding in top 10
Funds holding in top 10: 87 → 53 (-34)
Holders
835
Holding in Top 10
53
Calls
$714M
Puts
$494M
Top Buyers
| 1 | +$465M | |
| 2 | +$337M | |
| 3 | +$287M | |
| 4 |
Bank of New York Mellon
New York
|
+$220M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$154M |
Top Sellers
| 1 | -$434M | |
| 2 | -$243M | |
| 3 | -$194M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$187M |
| 5 |
First Eagle Investment Management
New York
|
-$144M |